Print
|
Close
A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors
Active:
No
Cancer Type:
Solid Tumor
NCT ID:
NCT01733004
Trial Phases:
Phase I
Protocol IDs:
MM-141-01-01-01 (primary)
Eligibility:
18 Years and older, Male and Female
Study Type:
Treatment
Study Sponsor:
Merrimack Pharmaceuticals
NCI Full Details:
http://clinicaltrials.gov/show/NCT01733004
Summary
This study is a Phase 1 and pharmacologic open-labeled dose-escalation trial using a "3+3" design, evaluating MM-141 at varying dose levels and frequencies.
**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts...
Click here to learn more about clinical trials
.